|
| 1 |
XU Rui-Hua, YUAN Zhong-Yu, GUAN Zhong-Zhen, LI Su Skate Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P. R. China;Reverse Effect of Genetically Modified Adenovirus H101 on Drug-resistance of A549/DDP Cells to Cisplatin[J];Chinese Journal of Cancer;2005-08 |
| 2 |
ZHANG Jun, ZHENG Jie, FANG Weigang, LI Hongmei, YOU Jiangfeng, WANG Jieliang, WU Bingquan (Department of Pathology, Beijing Medical University, Beijing 100083);THE CORRELATION BETWEEN MDM2 EXPRESSION AND p53 MUTATION IN HUMAN LUNG CANCER[J];JOURNAL OF BEIJING MEDICAL UNIVERSITY;1998-06 |
| 3 |
WANG Jinwan, SUN Yan, LIU Yongyu, YU Qitao, ZHANG Yiping, LI Kai, ZHU Yunzhong, ZHOU Qinghua, HOU Mei, GUAN Zhongzhen, LI Weilian, ZHUANG Wu, WANG Donglin, LIANG Houjie, QIN Fengzhan, LU Huishan, LIU Xiaoqing, SUN Hong, ZHANG Yanjun, WANG Jiejun, LUO Suxia, YANG Ruihe, TU Yuanrong, WANG Xiuwen, SONG Shuping, ZHOU Jingmin, YOU Lifen, WANG Jing, YAO Chen. Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, P.R.China;Results of randomized, multicenter, double-blind phase Ⅲ trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients[J];Chinese Journal of Lung Cancer;2005-04 |
| 4 |
TENG Jia-jun,HAN Bao-hui,SHEN Jie,GU Ai-qing,JIANG Li-yan,CHEN Yu-rong,QI Da-jiang.Department of Pulmonary,Shanghai Chest Hospital,Shanghai 200030,China;Clinical observation of chemotherapy combined endostar in advanced non-small cell lung cancer[J];Chinese Clinical Oncology;2008-02 |
| 5 |
PAN Jian-ping1,QU You-cun2,ZHU Wen-xian1,et al (1.Department of Immunology,School of Medical Sciences,Zhejiang University,Hangzhou,310031,China; 2.People's Hospital of Zhejiang Province,Hangzhou,310014,China);Stuey on significance of serum levels of intercellular adhesion molecule-1 in patients with lung cancer[J];JOURNAL OF PRACTICAL ONCOLOGY;2000-05 |
| 6 |
CHENG Xin,LI Kai Department of Throacic Oncology,Affiliated Tianjin Cancer Hospital of Tianjin Medical University,Tianjin 300060,China;Synergistic Effect of Endostatin and Cisplatin on Calu-6 Lung Cancer Cells[J];Tianjin Medical Journal;2008-05 |
| 7 |
Cai Peng; Liu Xu-Yi; Han Fu-Sheng et al (Beijing Institute for Cancer Research, Beijing);Establishment of Human Lung Adenocarcinoma Cisplatin-resistant Cell Line A_(549) DDP and the Mechanism of It's Drug Resistance[J];CHINESE JOURNAL OF CLINICAL ONCOLOGY;1995-08 |
| 8 |
LIU Yuxin, ZHENG Jie *, FANG Weigang, YOU Jiangfeng, WANG Jieliang, CUI Xianglin, WU Bingquan. * Department of Pathology, Beijing Medical University, Beijing 100083;Isolation and characterization of human prostate cancer cell subclones with different metastatic potential[J];CHINESE JOURNAL OF PATHOLOGY;1999-05 |
| 9 |
Zhu Wei-yong; Zheng Jie;Fang Wei-gang;et al(Department of Pathology , Beijing Medical University, Beijing 100083);The inhibition effect of retinoic acid on the invasion and metastasis abilities of metastatic human lung cancer cell subline[J];CHINESE JOURNAL OF PATHOLOGY;1994-06 |
| 10 |
Zhu Weiyong;Zheng Jie;Fang Weigang, et al (Department of Pathology, Beijing Medical University,Beijing l00083);Isolation and characterization of human lung cancer cell subline with different metastatic petential[J];CHINESE JOURNAL OF PATHOLOGY;1995-03 |
|